MiR-21 Expression Analysis in Budding Colon Cancer Cells by Confocal Slide Scanning Microscopy

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2018 Oct 27

PMID 30361805

Citations 10

Authors

Kirsten Nguyen Knudsen

Jan Lindebjerg

Alexandra Kalmar

Bela Molnar

Flemming Brandt Sorensen

Torben Frostrup Hansen

Boye Schnack Nielsen

Affiliations

Soon will be listed here.

Abstract

MicroRNA-21 (miR-21) expression in stromal fibroblastic cells in colorectal cancer is well-documented, whereas miR-21 expression in tumor budding cells (TBCs) is poorly described. TBCs are locally invasive carcinoma cells with increased metastatic properties and characteristics of epithelial to mesenchymal transition. This study was conducted to better characterize the expression of miR-21 in TBCs. First, chromogenic miR-21 in situ hybridization (ISH) staining was performed in 58 colon adenocarcinomas with evident TBCs. Then, to obtain unambiguous identification of miR-21 in the TBCs, twenty cases were selected for an additional multiplex fluorescence analysis combining miR-21 ISH with cytokeratin and laminin-5γ2 immunofluorescence. Employing confocal slide scanning microscopy, comprehensive digital images of the invasive front (10-40 mm) were obtained from 16 of the 20 cases, and miR-21 expression was evaluated in cytokeratin-positive TBCs. The high resolution of the confocal digital slide images allowed a detailed examination of the confocal stacks of the multiplex-stained tissue sections. The cases with the highest fraction of miR-21 positive TBCs were all stage III cancers defined by the presence of regional lymph node metastasis. Some of the miR-21 positive TBCs were also laminin-5γ2 positive. The confocal image stacks also revealed that some TBCs were actually directly connected to malignant glands. In conclusion, miR-21 expression was unambiguously identified in TBCs by evaluation of digital slides obtained by confocal slide scanning microscopy. In addition, the digital confocal slides provided a more detailed understanding of local cancer cell invasion by allowing evaluation of the cell structures in three dimensions.

Citing Articles

Architectural organization and molecular profiling of 3D cancer heterospheroids and their application in drug testing.

Nielsen B, Madsen N, Larsen J, Skandorff I, Gad M, Holmstrom K Front Oncol. 2024; 14:1386097.

PMID: 39011470 PMC: 11246882. DOI: 10.3389/fonc.2024.1386097.

Tumor budding as a potential prognostic marker in determining the behavior of primary liver cancers.

Unal B, Celik M, Gedik E, Bassorgun C, Elpek G World J Hepatol. 2023; 15(6):775-785.

PMID: 37397937 PMC: 10308291. DOI: 10.4254/wjh.v15.i6.775.

Circ-LocNet: A Computational Framework for Circular RNA Sub-Cellular Localization Prediction.

Asim M, Ibrahim M, Malik M, Dengel A, Ahmed S Int J Mol Sci. 2022; 23(15).

PMID: 35897818 PMC: 9329987. DOI: 10.3390/ijms23158221.

Monocyte Infiltration and Differentiation in 3D Multicellular Spheroid Cancer Models.

Madsen N, Nielsen B, Nhat S, Skov S, Gad M, Larsen J Pathogens. 2021; 10(8).

PMID: 34451433 PMC: 8399809. DOI: 10.3390/pathogens10080969.

Detection of lncRNA by LNA-Based In Situ Hybridization in Paraffin-Embedded Cancer Cell Spheroids.

Nielsen B, Larsen J, Hoffding J, Nhat S, Madsen N, Moller T Methods Mol Biol. 2021; 2348:123-137.

PMID: 34160803 DOI: 10.1007/978-1-0716-1581-2_8.

References

Jorgensen S, Baker A, Moller S, Nielsen B . Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods. 2010; 52(4):375-81. DOI: 10.1016/j.ymeth.2010.07.002. View

Sempere L, Christensen M, Silahtaroglu A, Bak M, Heath C, Schwartz G . Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007; 67(24):11612-20. DOI: 10.1158/0008-5472.CAN-07-5019. View

Neil M, Juskaitis R, Wilson T . Method of obtaining optical sectioning by using structured light in a conventional microscope. Opt Lett. 2008; 22(24):1905-7. DOI: 10.1364/ol.22.001905. View

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M . Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2008; 72(5-6):397-402. DOI: 10.1159/000113489. View

Ueno H, Price A, Wilkinson K, Jass J, Mochizuki H, Talbot I . A new prognostic staging system for rectal cancer. Ann Surg. 2004; 240(5):832-9. PMC: 1356489. DOI: 10.1097/01.sla.0000143243.81014.f2. View

Grigore A, Jolly M, Jia D, Farach-Carson M, Levine H . Tumor Budding: The Name is EMT. Partial EMT. J Clin Med. 2016; 5(5). PMC: 4882480. DOI: 10.3390/jcm5050051. View

Kajiwara Y, Ueno H, Hashiguchi Y, Shinto E, Shimazaki H, Mochizuki H . Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer. Am J Clin Pathol. 2011; 136(1):138-44. DOI: 10.1309/AJCP63NRBNGCTXVF. View

Schetter A, Leung S, Sohn J, Zanetti K, Bowman E, Yanaihara N . MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008; 299(4):425-36. PMC: 2614237. DOI: 10.1001/jama.299.4.425. View

Krichevsky A, Gabriely G . miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009; 13(1):39-53. PMC: 3823035. DOI: 10.1111/j.1582-4934.2008.00556.x. View

10.

Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart L . Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A. 2001; 98(18):10356-61. PMC: 56965. DOI: 10.1073/pnas.171610498. View

11.

Zlobec I, Lugli A . Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2011; 1(7):651-61. PMC: 3248128. DOI: 10.18632/oncotarget.199. View

12.

Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K . Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 1995; 55(18):4132-9. View

13.

Ortega F, Lorente J, Garcia Puche J, Ruiz M, Sanchez-Martin R, de Miguel-Perez D . miRNA in situ hybridization in circulating tumor cells--MishCTC. Sci Rep. 2015; 5:9207. PMC: 4361864. DOI: 10.1038/srep09207. View

14.

Knudsen K, Nielsen B, Lindebjerg J, Hansen T, Holst R, Sorensen F . microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution. PLoS One. 2015; 10(10):e0140503. PMC: 4605595. DOI: 10.1371/journal.pone.0140503. View

15.

Ohtsuki K, Koyama F, Tamura T, Enomoto Y, Fujii H, Mukogawa T . Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res. 2008; 28(3B):1831-6. View

16.

Langhorst M, Schaffer J, Goetze B . Structure brings clarity: structured illumination microscopy in cell biology. Biotechnol J. 2009; 4(6):858-65. DOI: 10.1002/biot.200900025. View

17.

Kang W, Lee J, Oh S, Lee S, Jung C . Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse. BMC Gastroenterol. 2015; 15:2. PMC: 4308857. DOI: 10.1186/s12876-015-0227-0. View

18.

Reddy K . MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015; 15:38. PMC: 4424445. DOI: 10.1186/s12935-015-0185-1. View

19.

Karamitopoulou E, Zlobec I, Kolzer V, Kondi-Pafiti A, Patsouris E, Gennatas K . Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer. Mod Pathol. 2012; 26(2):295-301. DOI: 10.1038/modpathol.2012.155. View

20.

Kim V . MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005; 6(5):376-85. DOI: 10.1038/nrm1644. View